A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes
Status:
Completed
Trial end date:
2019-04-02
Target enrollment:
Participant gender:
Summary
This study compares the movement of Belatacept drug products, whose active pharmaceutical
ingredient has been manufactured by 2 different processes, into, through and out of the body
(pharmacokinetics/PK) of healthy volunteers. Eligible participants will be randomly assigned
to one of two groups, and will receive a single dose of a belatacept product once during a
4-day stay at a study site.